The enzyme-linked immunosorbent assay results of eight reports suggested that serum IGF-1 levels were decreased in patients with OSAHS compared with those of patients in the control group (SMD=-2.36, 95%CI= -3.39–1.43, P< 0.001). The gene discussed is IGF1; the disease is obstructive sleep apnea syndrome.